DeepLife - About the company
DeepLife is a series A company based in Paris (France), founded in 2019 by Jonathan Baptista. It operates as a Provider of AI-based drug discovery and omics analysis tool for researchers. DeepLife has raised $16.4M in funding from Turenne Groupe and YZR Capital. The company has 490 active competitors, including 102 funded and 39 that have exited. Its top competitors include companies like Benchling, Helix and Cellworks.
Company Details
Provider of AI-based drug discovery and omics analysis tool for researchers. The company has developed tools that are AI-enabled for the process of drug discovery. The tool assists in provided insights for target protein for the drug for an individual patient. The tools use machine learning technology to identify molecular triggers for the drug and target identification. It has features to process biological data, tools for genomic screening, and more.
- Website
- www.deeplife.co/
- Social
- Email ID
- *****@deeplife.co
- Phone Number
- +33 **********
Key Metrics
Founded Year
2019
Location
Paris, France
Stage
Series A
Total Funding
$16.4M in 2 rounds
Latest Funding Round
Investors
Ranked
82nd among 490 active competitors
Employee Count
10 as on Jul 01, 2024
Similar Companies
Legal entities associated with DeepLife
DeepLife is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
DeepLife CIN: 852661230 , France, Deadpooled | Jul 23, 2019 | - | - | - |
Sign up to download DeepLife's company profile
DeepLife's funding and investors
DeepLife has raised a total funding of $16.4M over 2 rounds. Its first funding round was on Oct 18, 2022. Its latest funding round was a Series A round on Dec 16, 2024 for €*****. 4 investors participated in its latest round. DeepLife has 9 institutional investors and 5 angel investors.
Here is the list of recent funding rounds of DeepLife:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 16, 2024 | 6495609 | Series A | 5244242 | 8635083 | 6829953 | 2836461 |
Oct 18, 2022 | 3308076 | Series A | 8145217 | 6183371 | 3669790 |
Access funding benchmarks and valuations. Sign up today!View details of DeepLife's funding rounds and investors
DeepLife's founders and board of directors
Founder? Claim ProfileThe founders of DeepLife is Jonathan Baptista. Jonathan Baptista is the CEO of DeepLife.
Here are the details of DeepLife's key team members:
- Jonathan Baptista: Co-Founder & CEO of DeepLife. Contact Info: 1 email address
View details of DeepLife's Founder profiles and Board Members
DeepLife's employee count trend
DeepLife has 10 employees as of Jul 24. Here is DeepLife's employee count trend over the years:
Uncover DeepLife's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
DeepLife's Competitors and alternates
Top competitors of DeepLife include Benchling, Helix and Cellworks. Here is the list of Top 10 competitors of DeepLife, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Benchling 2012, San Francisco (United States), Series F | Provider of a cloud-based bioinformatics platform for biotech research | $412M | 73/100 | |
2nd |  Helix 2015, San Francisco (United States), Series E | Provider of a genomic database for clinical research | $435M | 71/100 | |
3rd | Cellworks 2005, San Jose (United States), Series B | Developer of a biosimulation platform | $16.5M | 65/100 | |
4th |  NTxBio 2016, Santa Fe (United States), Series B | Provider of bio informatics platform to develops biologics and therapeutics | $85.1M | 61/100 | |
5th |  Recludix Pharma 2020, San Diego (United States), Series A | Provider of the online platform for drug discovery and development | $60M | 60/100 | |
6th | Immuneering Corporation 2019, Cambridge (United States), Public | Provider of an AI-enabled bioinformatics platform for clinical solutions | $79M | 60/100 | |
7th | Cloud-based platform for storing and managing genomic data | $20M | 59/100 | ||
8th |  Latch 2021, San Francisco (United States), Series A | Provider of a web-based platform for genomic bioinformatics | $33M | 58/100 | |
9th | Genedata 1997, Basel (Switzerland), Acquired | Software solutions for drug discovery, industrial biotechnology, and life science research | - | 58/100 | |
10th |  Inpharmatica 1998, London (United Kingdom), Acquired | Developer of predictive informatics based platform for drug discovery | $75M | 58/100 | |
82nd | Provider of AI-based drug discovery and omics analysis tool for researchers | $16.4M | 37/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on DeepLife's competitors? Click here to see the top ones
DeepLife's Investments and acquisitions
DeepLife has made no investments or acquisitions yet.
News related to DeepLife
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about DeepLife
Explore our recently published companies
- Dl-Dental-2000 - Germany based, Unfunded company
- Kardiokl - Germany based, Unfunded company
- Blk-Care - Unfunded company
- DRPU Software - Ghaziabad based, 2008 founded, Public company
- Independent School District 625 - United States based, Funding Raised company
- Scioto Valley Solar One - Columbus based, 2021 founded, Funding Raised company
